The Veterinary Oncology Market report points out national and global business prospects and competitive conditions for veterinary oncology. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for veterinary oncology. The veterinary oncology market has been segmented by animal type (companion animal (equine, canine, and feline), and livestock animal), by therapy type (chemotherapy, combination therapy, immunotherapy, and targeted therapy), by mode of administration (oral and intravenous), by application (canine lymphoma, osteosarcoma (osa), mast cell cancer, melanoma, and multiple myeloma), by distribution channel (hospital pharmacies, government agencies, and retail pharmacies). Historical background for the demand of veterinary oncology has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand veterinary oncology have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Animal Type:

• Companion Animal
  • Equine
  • Canine
  • Feline
• Livestock Animal

By Therapy Type:

• Chemotherapy
• Combination Therapy
• Immunotherapy
• Targeted Therapy

By Mode of Administration:

• Oral
• Intravenous

By Application:

• Canine Lymphoma
• Osteosarcoma (OSA)
• Mast Cell Cancer
• Melanoma
• Multiple Myeloma

By Distribution Channel:

• Hospital Pharmacies
• Government Agencies
• Retail Pharmacies
  

By Region:

North America Veterinary Oncology Market

• North America, by Country
  • US
  • Canada
  • Mexico
• North America, by Animal Type
• North America, by Therapy Type
• North America, by Mode of Administration
• North America, by Application 
• North America, by Distribution Channel 

Europe Veterinary Oncology Market

• Europe, by Country
  • Germany
  • Russia
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Rest of Europe 
• Europe, by Animal Type
• Europe, by Therapy Type
• Europe, by Mode of Administration
• Europe, by Application 
• Europe, by Distribution Channel 

Asia Pacific Veterinary Oncology Market

• Asia Pacific, by Country
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific 
• Asia Pacific, by Animal Type
• Asia Pacific, by Therapy Type
• Asia Pacific, by Mode of Administration
• Asia Pacific, by Application 
• Asia Pacific, by Distribution Channel 

Middle East & Africa Veterinary Oncology Market

• Middle East & Africa, by Country 
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
• Middle East & Africa, by Animal Type
• Middle East & Africa, by Therapy Type
• Middle East & Africa, by Mode of Administration
• Middle East & Africa, by Application 
• Middle East & Africa, by Distribution Channel 

South America Veterinary Oncology Market

• South America, by Country 
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• South America, by Animal Type
• South America, by Therapy Type
• South America, by Mode of Administration
• South America, by Application 
• South America, by Distribution Channel 

Major Companies: Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

• To estimate market size for veterinary oncology market on regional and global basis.
• To identify major segments in veterinary oncology market and evaluate their market shares and demand.
• To provide a competitive scenario for the veterinary oncology market with major developments observed by key companies in the historic years.
• To evaluate key factors governing the dynamics of veterinary oncology market with their potential gravity during the forecast period.

Reasons to Buy This Report:

• Provides niche insights for decision about every possible segment helping in strategic decision making process.
• Market size estimation of the veterinary oncology market on a regional and global basis.
• A unique research design for market size estimation and forecast.
• Identification of major companies operating in the market with related developments
• Exhaustive scope to cover all the possible segments helping every stakeholder in the veterinary oncology

Customization:

This study is customized to meet your specific requirements:

• By Segment
• By Sub-segment
• By Region/Country
• Product Specific Competitive Analysis

For more information, contact: [email protected]